Matoba Satoaki | Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PE-448 Hypoxia-Induced p53 Deteriorates Cardiac Energetics and Apoptotic Cell Death via TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator)(PE075,Heart Failure (Pathophysiology) (M),Poster Session (English),The 73rd Annual Scientific Meeting of the Ja
Predictors of In-Hospital Prognosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Requiring Mechanical Support Devices
PJ-588 Rehabilitation after Angiogenic Cell Therapy for the Critical Limb Ischemia(PJ099,Exercise Test/Cardiac Rehabilitation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PE-394 p53 and SCO2 (Synthesis of Cytochrome c Oxidase 2) Augment the Progression of Diabetic Cardiomyopathy(PE066,Diabetes 2 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
OE-232 p53 as a New Target of Cardiac Metabolism(Metabolism/Biochemistry/Energetics(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
1 Intracoronary Transplantation of Non-Expanded Peripheral Blood Mononuclear Cells in Patients with Acute Myocardial Infarction(Symposium 12 (SY-12) (M) Clinical Experiences of Regenerative Medicine in Cardiovascular Diseases,Special Program,The 72nd Annu
Intracoronary Transplantation of Non-Expanded Peripheral Blood-Derived Mononuclear Cells Promotes Improvement of Cardiac Function in Patients With Acute Myocardial Infarction
OE-318 Calcium-dependent Tyrosine Kinase Pyk2 Aggravate Myocardial Ischemia by Promoting Apoptosis, Revealed by Knockout Mice(Molecular biology, myocardium-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Spironolactone Modulates Expressions of Cardiac Mineralocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase 2 and Prevents Ventricular Remodeling in Post-Infarct Rat Hearts
In-Hospital Outcomes of Primary Percutaneous Coronary Interventions Performed at Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery
2 p53 : New Therapeutic Target for Heart Failure(Novel Molecular Mechanisms and Therapeutic Strategies for Heart Failure,Japan-Korea Cardiovascular Conference,Presidential Planning Program (M),Special Program,The 72nd Annual Scientific Meeting of the Japa
6 Therapeutic Angiogenesis for Patients with Chronic Limb Ischemia by Autologous Transplantation of Bone Marrow Mononuclear Cells : 3-Year Results of the TACT Trial, Long Term Prognosis, Efficacy and Safety(Late Breaking Clinical Trials I,Special Program,
OJ-252 Overexpression of Tie2-promoted Activated FGFR2 in Endothelium Enhances Angiogenesis and Induces Cardioprotection via Akt Signaling Pathway in Mice Myocardial Infarction(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japan
OE-208 p53 Regulates Exercise Capacity in Mouse(Genetics/Genetically engineered models/Gene therapy-1(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Predictors of nonoptimal coronary flow after primary percutaneous coronary intervention with stent implantation for acute myocardial infarction
Influence of previous myocardial infarction site on in-hospital outcome after primary percutaneous coronary intervention for repeat myocardial infarction
Clinical manifestations and effects of primary percutaneous coronary intervention for patients with delayed pre-hospital time in acute myocardial infarction

もっと見る

スポンサーリンク